17th week of 2019 patent applcation highlights part 10 |
Patent application number | Title | Published |
20190117617 | COMPOUND AND METHOD FOR TREATMENT OF DISEASES AND DISORDERS | 2019-04-25 |
20190117618 | ISOFLAVONOID COMPOSITION WITH IMPROVED PHARMACOKINETICS | 2019-04-25 |
20190117619 | USE OF CANNABIDIOLIC ACID IN THE TREATMENT OF AUTISM SPECTRUM DISORDER AND ASSOCIATED DISORDERS | 2019-04-25 |
20190117620 | CHEMOTHERAPY IMPROVEMENTS | 2019-04-25 |
20190117621 | STABILIZED STATIN FORMULATIONS | 2019-04-25 |
20190117622 | PANOBINOSTAT DOSAGES FOR MULTIPLE MYELOMA | 2019-04-25 |
20190117623 | ALPHA-1-ADRENERGIC RECEPTOR AGONIST THERAPY | 2019-04-25 |
20190117624 | THERAPEUTIC AGENT FOR INFLAMMATORY BOWEL DISEASES | 2019-04-25 |
20190117625 | METHOD OF TREATING MULTIPLE SCLEROSIS | 2019-04-25 |
20190117626 | METHOD OF TREATING MULTIPLE SCLEROSIS | 2019-04-25 |
20190117627 | POLYMORPHIC FORMS AND PROCESS | 2019-04-25 |
20190117628 | Ifetroban Treatment for Systemic Sclerosis | 2019-04-25 |
20190117629 | Sustained Release Pharmaceutical Compositions and Methods of Use | 2019-04-25 |
20190117630 | METHODS AND DRUG COMPOSITIONS FOR TREATING LYME DISEASE | 2019-04-25 |
20190117631 | NANOLIPOSOMES FOR SUSTAINED DELIVERY OF TACROLIMUS FOR TREATMENT OF ANTERIOR SEGMENT EYE DISEASES | 2019-04-25 |
20190117632 | METHODS OF TREATING DEVELOPMENTAL DISORDERS WITH GABOXADOL | 2019-04-25 |
20190117633 | TREATMENT OF DEPRESSIVE DISORDERS | 2019-04-25 |
20190117634 | Treatment of Vulvodynia | 2019-04-25 |
20190117635 | METHODS FOR TREATMENT OF MELANOMA | 2019-04-25 |
20190117636 | 5-HT2A SEROTONIN RECEPTOR INVERSE AGONISTS OR ANTAGONISTS FOR USE IN REDUCING AMYLOID-BETA PEPTIDES AND ACCUMULATION OF AMYLOID PLAQUES | 2019-04-25 |
20190117637 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATMENT OF PAIN | 2019-04-25 |
20190117638 | SELECTIVE NR2B ANTAGONISTS | 2019-04-25 |
20190117639 | COMBINATION OF LAQUINIMOD AND PRIDOPIDINE FOR TREATING NEURODEGENERATIVE DISORDERS, IN PARTICULAR HUNTINGTON'S DISEASE | 2019-04-25 |
20190117640 | DRUG COMBINATIONS FOR REDUCING CELL VIABILITY AND/OR CELL PROLIFERATION | 2019-04-25 |
20190117641 | TAF1 INHIBITORS FOR THE THERAPY OF CANCER | 2019-04-25 |
20190117642 | TARGETING AMP DEAMINASE 2 FOR AMELIORATING CRAVING FOR SUGAR AND OTHER SUBSTANCES | 2019-04-25 |
20190117643 | Methods For Treating Pancreatic Cancer Using Combination Therapies Comprising Liposomal Irinotecan | 2019-04-25 |
20190117644 | Methods For Treating Pancreatic Cancer Using Combination Therapies | 2019-04-25 |
20190117645 | ORAL FORMULATIONS AND LIPOPHILIC SALTS OF METHYLNALTREXONE | 2019-04-25 |
20190117646 | ORAL FORMULATIONS AND LIPOPHILIC SALTS OF METHYLNALTREXONE | 2019-04-25 |
20190117647 | Granule Formulation for Oral Administration | 2019-04-25 |
20190117648 | Piperazine-Substituted Benzothiophenes For Treatment of Mental Disorders | 2019-04-25 |
20190117649 | COMBINATION THERAPY FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA | 2019-04-25 |
20190117650 | HETEROARYL COMPOUNDS AND USES THEREOF | 2019-04-25 |
20190117651 | COMPOSITION FOR STIMULATING SIRTUIN ACTIVITY | 2019-04-25 |
20190117652 | COMBINATION OF RAF INHIBITORS AND TAXANES | 2019-04-25 |
20190117653 | SYSTEMS AND METHODS FOR TREATING BACTERIAL INFECTION | 2019-04-25 |
20190117654 | Compounds and Their Use for Reducing Uric Acid Levels | 2019-04-25 |
20190117655 | Treatment of Biliary Duct Cancer | 2019-04-25 |
20190117656 | FUSED HETEROTRICYCLIC ORGANIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND MEDICAL USES THEREOF | 2019-04-25 |
20190117657 | METHOD OF INHIBITING HIGH FAT DIET-RELATED CONDITIONS | 2019-04-25 |
20190117658 | NOVEL COMPOSITIONS AND METHODS | 2019-04-25 |
20190117659 | METHODS FOR TREATING RENAL DISEASE | 2019-04-25 |
20190117660 | Pharmaceutical Compositions and Methods for Stabilizing the Same | 2019-04-25 |
20190117661 | THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE | 2019-04-25 |
20190117662 | THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE | 2019-04-25 |
20190117663 | COMPOSITIONS AND METHODS FOR TREATING CANCER | 2019-04-25 |
20190117664 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TH2 MEDIATED DISEASES | 2019-04-25 |
20190117665 | SALTS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF | 2019-04-25 |
20190117666 | DRUG FOR PREVENTING AND/OR TREATING POLYCYSTIC KIDNEY DISEASE | 2019-04-25 |
20190117667 | ANTICANCER ACTIVITY OF PLATINUM(II) TETRASELENONE COMPLEXES | 2019-04-25 |
20190117668 | COMPOSITIONS AND METHODS FOR TREATING DISORDERS OF CIRCADIAN AND DIURNAL RHYTHMS USING PROKINETICIN 2 AGONISTS AND ANTAGONISTS | 2019-04-25 |
20190117669 | Methods for Treating NSAID-Induced Cardiovascular, Cerebrovascular, or Renovascular Adverse Events | 2019-04-25 |
20190117670 | LONGER-ACTING PROGESTIN PRODRUG CONTRACEPTIVES | 2019-04-25 |
20190117671 | OPTIMIZING MIFEPRISTONE LEVELS FOR CUSHING'S PATIENTS | 2019-04-25 |
20190117672 | TARGETING NCCA-ATP CHANNEL FOR ORGAN PROTECTION FOLLOWING ISCHEMIC EPISODE | 2019-04-25 |
20190117673 | GANAXOLONE FORMULATION AND USE THEREOF | 2019-04-25 |
20190117674 | METHOD OF TREATMENT USING NANOPARTICULATE GANAXOLONE FORMULATIONS | 2019-04-25 |
20190117675 | Compositions And Methods To Treat And/Or Prevent Vision Disorders Of The Lens Of The Eye | 2019-04-25 |
20190117676 | CONCOMITANT ADMINISTRATION OF GLUCOCORTICOID RECEPTOR MODULATORS AND CYP3A INHIBITORS | 2019-04-25 |
20190117677 | COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING DISEASE | 2019-04-25 |
20190117678 | Method of Treating Acute Coronary Syndromes | 2019-04-25 |
20190117679 | IMIDAZOPYRIDINES SYK INHIBITORS | 2019-04-25 |
20190117680 | DENDRIMERIC PLATFORM FOR CONTROLLED RELEASE OF DRUGS | 2019-04-25 |
20190117681 | GLYCOGEN AND PHYTOGLYCOGEN NANOPARTICLES AS IMMUNOSUPPRESSIVE COMPOUNDS, AND COMPOSITIONS AND METHODS OF USE THEREOF | 2019-04-25 |
20190117682 | BIO-INSPIRED POLYMERS FOR USE AS SYNTHETIC MUCINS | 2019-04-25 |
20190117683 | ALGINATE OLIGOMERS FOR THE TREATMENT OR PREVENTION OF MICROBIAL OVERGROWTH IN THE INTESTINAL TRACT | 2019-04-25 |
20190117684 | Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6 | 2019-04-25 |
20190117685 | PROCESS FOR THE IDENTIFICATION OF COMPOUNDS FOR TREATING CANCER | 2019-04-25 |
20190117686 | PHARMACEUTICAL COMPOSITIONS | 2019-04-25 |
20190117687 | COGNITIVE FUNCTION-REMEDYING AGENT | 2019-04-25 |
20190117688 | COMPOSITIONS COMPRISING SECRETED EXTRACELLULAR VESICLES OF CELLS EXPRESSING NFATC4 USEFUL FOR THE TREATMENT OF CANCER | 2019-04-25 |
20190117689 | COMPOSITIONS AND METHODS RELATED TO POLYCYTOTOXIC T CELLS | 2019-04-25 |
20190117690 | USE OF HETERODIMERIC IL-15 IN ADOPTIVE CELL TRANSFER | 2019-04-25 |
20190117691 | PD-1 CAR-T CELL, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | 2019-04-25 |
20190117692 | ENGAGER CELLS FOR IMMUNOTHERAPY | 2019-04-25 |
20190117693 | NOVEL PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPY AGAINST HEAD AND NECK SQUAMOUS CELL CARCINOMA AND OTHER CANCERS | 2019-04-25 |
20190117694 | METHODS OF PREVENTING PLATELET ALLOIMMUNIZATION AND ALLOIMMUNE PLATELET REFRACTORINESS AND INDUCTION OF TOLERANCE IN TRANSFUSED RECIPIENTS | 2019-04-25 |
20190117695 | ISOLATED RENAL CELLS AND USES THEREOF | 2019-04-25 |
20190117696 | TISSUE REPAIR BY STEM CELL RECRUITMENT AND DIFFERENTIATION | 2019-04-25 |
20190117697 | METHODS FOR TREATING PAIN | 2019-04-25 |
20190117698 | METHODS AND COMPOSITIONS FOR TREATING VASCULAR-RELATED DEGENERATIVE NEUROLOGICAL DISORDERS | 2019-04-25 |
20190117699 | THERAPEUTIC USE OF ELECTROACUPUNCTURE-INDUCED MESENCHYMAL STEM CELLS | 2019-04-25 |
20190117700 | SYNAPSE FORMATION AGENT | 2019-04-25 |
20190117701 | MESENCHYMAL STEM CELL EXPRESSING AT LEAST ONE CELL SURFACE MARKER SELECTED FROM THE GROUP CONSISTING OF CD201, CD46, CD56, CD147, AND CD165, METHOD FOR PREPARING THE SAME, PHARMACEUTICAL COMPOSITION CONTAINING THE MESENCHYMAL STEM CELLS, AND METHOD FOR PREPARING THE SAME | 2019-04-25 |
20190117702 | USE OF ASC AND ASC-CM TO TREAT ARDS, SARS, AND MERS | 2019-04-25 |
20190117703 | IMMUNOLOGICAL TREATMENT OF LIVER FAILURE | 2019-04-25 |
20190117704 | CULTURE, DEVICE, AND COMPOSITION FOR PRODUCING ADULT OLIGODENDROCYTE-TYPE 2 ASTROCYTE PROGENITOR CELLS AND PROLIFERATING OLIGODENDROCYTE-TYPE 2 ASTROCYTE PROGENITOR CELLS | 2019-04-25 |
20190117705 | COMPOSITIONS COMPRISING HUMAN PLACENTAL PERFUSATE CELLS, SUBPOPULATIONS THEREOF, AND THEIR USES | 2019-04-25 |
20190117706 | FEED ADDITIVE COMPOSITION | 2019-04-25 |
20190117707 | LACTOBACILLUS SUPPLEMENT FOR ALLEVIATING TYPE 1 DIABETES | 2019-04-25 |
20190117708 | PROBIOTIC DELIVERY SYSTEMS | 2019-04-25 |
20190117709 | METHOD AND SYSTEM FOR REDUCING THE LIKELIHOOD OF DEVELOPING LIVER CANCER IN AN INDIVIDUAL DIAGNOSED WITH NON-ALCOHOLIC FATTY LIVER DISEASE | 2019-04-25 |
20190117710 | METHODS FOR REGULATING ENDOGENOUS PRODUCTION OF CHECKPOINT PROTEINS | 2019-04-25 |
20190117711 | CHIMERIC VSV VIRUS COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATMENT OF CANCER | 2019-04-25 |
20190117712 | EXTRACTS OF MICROALGAE AND THEIR APPLICATION | 2019-04-25 |
20190117713 | ANTIBACTERIAL COMPOSITION | 2019-04-25 |
20190117714 | Use of a composition for lowering cholesterol level in a mammal, a method for its preparation and a product and a food additive comprising said composition | 2019-04-25 |
20190117715 | COMPOSITION FOR IMPROVING RECOGNITION FUNCTIONS | 2019-04-25 |
20190117716 | FATTY ACID COMPOSITION AND PHARMACEUTICAL PREPARATION AND APPLICATION THEREOF | 2019-04-25 |